Prostaglandin-induced hair growth

Survey of Ophthalmology

Volumn 47, Issue 4 SUPPL. 1, 2002, Pages

  Johnstone, Murray A ^a,c   Albert, Daniel M ^b  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Arnold Medical Pavilion   (United States)

Author keywords

Alopecia; Anagen; Eyelash; Glaucoma; Hair; Hair follicle; Hair growth; Hypertrichosis; Latanoprost; Prostaglandin

Indexed keywords

BENOXAPROFEN; CALCIMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CELL ADHESION MOLECULE; DIAZOXIDE; ERYTHROPOIETIN; ESTROGEN RECEPTOR; FINASTERIDE; FLUPROSTENOL; GROWTH HORMONE; LATANOPROST; MINOXIDIL; MINOXIDIL SULFATE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN RECEPTOR; RETINOIC ACID; VIPROSTOL;

CLINICAL TRIAL; CORRELATION ANALYSIS; EMBRYO DEVELOPMENT; EYELASH; GLAUCOMA; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HYPERTRICHOSIS; KERATINIZATION; MALE TYPE ALOPECIA; MELANOCYTE; NONHUMAN; PATIENT EDUCATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0036669289     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00307-7     Document Type: Article

References (129)

1. Ahmad W., Faiyaz ul Haque M, Brancolini Vet al. Alopecia universalis associated with a mutation in the human hairless gene. Science. 279:1998;720-724.
2. Alberts B., Bray D., Lewis J.et al. Cell signaling. Alberts B., Bray D., Lewis J.et al. Molecular Biology of the Cell. 1994;734-758 Garland Publishing, Inc, New York. ed 3,
3. Alberts B, Bray D, Lewis J, et al: Cellular mechanisms of development, in Alberts B, Bray D, Lewis J, et al (eds): Molecular Biology of the Cell. New York, Garland Publishing, ed 3, 1994, pp 1037-139
4. Alm A., Camras C.B., Watson P.G. Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States. Surv Ophthalmol. 41(Suppl 2):1997;S105-S110.
5. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 102:1995;1743-1752.
6. Arase S., Sadamoto Y., Katoh S.et al. Co-culture of human hair follicles and dermal papillae in a collagen matrix. J Dermatol. 17:1990;667-676.
7. Baden H.P. Structure, composition and physiology of hair. Baden H.P. Diseases of the Hair & Nails. 1987;105-114 Year Book Medical Publishers, Chicago.
8. Bartosova L. Biology of hair growth. Curr Probl Dermatol. 12:1984;1-58.
9. Bencini P.L., Montagnino G., Sala F.et al. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica. 172:1986;24-30.
10. Bentley-Phillips C.B., Paulli-Jorgensen H., Marks R. The effects of prostaglandins E1 and F2alpha on epidermal growth. Arch Dermatol Res. 257:1977;233-237.
11. Botchkarev V.A., Botchkareva N.V., Welker P.et al. A new role for neurotrophins. involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control FASEB J. 13:1999;395-410.
12. Botchkarev V.A., Eichmuller S., Johansson O., Paus R. Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol. 386:1997;379-395.
13. Buhl A.E., Waldon D.J., Conrad S.J.et al. Potassium channel conductance. a mechanism affecting hair growth both in vitro and in vivo J Invest Dermatol. 98:1992;315-319.
14. Burton J.L., Schutt W.H., Caldwell I.W. Hypertrichosis due to diazoxide. Br J Dermatol. 93:1975;707-711.
15. Camras C.B., Wax M.B., Ritch R.et al. Latanoprost treatment for glaucoma. effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group Am J Ophthalmol. 126:1998;390-399.
16. Cohen D.J., Loertscher R., Rubin M.F.et al. Cyclosporine. a new immunosuppressive agent for organ transplantation Ann Intern Med. 101:1984;667-682.
17. Commo S., Bernard B.A. The distribution of alpha 2 beta 1, alpha 3 beta 1 and alpha 6 beta 4 integrins identifies distinct subpopulations of basal keratinocytes in the outer root sheath of the human anagen hair follicle. Cell Mol Life Sci. 53:1997;466-471.
18. Cormia F.E. vasculature of the normal scalp. Arch Dermatol. 88:1963;692-701.
19. Cotsarelis G., Sun T.T., Lavker R.M. Label-retaining cells reside in the bulge area of pilosebaceous unit. implications for follicular stem cells, hair cycle, and skin carcinogenesis Cell. 61:1990;1329-1337.
20. Danilenko D.M., Ring B.D., Pierce G.F. Growth factors and cytokines in hair follicle development and cycling. recent insights from animal models and the potentials for clinical therapy Mol Med Today. 2:1996;460-467.
21. Darnell J., Lodish H. Cell to cell signaling. hormones and receptors Darnell J., Lodish H. Molecular Cell Biology. 1990;738-743 WH Freeman and Company, New York.
22. Delaunay M: [Cutaneous side effects of antitumor chemotherapy]. Ann Dermatol Venereol 116:347-61, 1989
23. Dunagin W.G. Clinical toxicity of chemotherapeutic agents. dermatologic toxicity Semin Oncol. 9:1982;14-22.
24. Dutkiewicz R., Albert D.M., Levin L.A. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines. Exp Eye Res. 70:2000;563-569.
25. Fagot D., Buquet-Fagot C., Mester J. Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts. comparison with phorbol esters and insulin Endocrinology. 132:1993;1729-1734.
26. Fuchs E. Beauty is skin deep. the fascinating biology of the epidermis and its appendages Harvey Lect. 94:1998;47-77.
27. Gandolfi S., Simmons S.T., Sturm R.et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 18:2001;110-121.
28. Geng L., Hanson W.R., Malkinson F.D. Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation. Int J Radiat Biol. 61:1992;533-537.
29. Gilliam A.C., Kremer I.B., Yoshida Y.et al. The human hair follicle. a reservoir of CD40+ B7-deficient Langerhans cells that repopulate epidermis after UVB exposure J Invest Dermatol. 110:1998;422-427.
30. Godwin A.R., Capecchi M.R. Hoxc13 mutant mice lack external hair. Genes Dev. 12:1998;11-20.
31. Hansen L.A., Alexander N., Hogan M.E.et al. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol. 150:1997;1959-1975.
32. Hanson W.R., Pelka A.E., Nelson A.K., Malkinson F.D. Subcutaneous or topical administration of 16,16 dimethyl prostaglandin E2 protects from radiation-induced alopecia in mice. Int J Radiat Oncol Biol Phys. 23:1992;333-337.
33. Hardy M.H., Vielkind U. Changing patterns of cell adhesion molecules during mouse pelage hair follicle development. 1. Follicle morphogenesis in wild-type mice. Acta Anat (Basel). 157:1996;169-182.
34. Harmon C.S., Nevins T.D., Bollag W.B. Protein kinase C inhibits human hair follicle growth and hair fibre production in organ culture. Br J Dermatol. 133:1995;686-693.
35. Headington J.T. Hair follicle biology and topical minoxidil. possible mechanisms of action Dermatologica. 175(Suppl 2):1987;19-22.
36. Hebert J.M., Rosenquist T., Gotz J., Martin G.R. FGF5 as a regulator of the hair growth cycle. evidence from targeted and spontaneous mutations Cell. 78:1994;1017-1025.
37. Houssay A.B., Arias N.H., Davison T.A., Epper C.E. Effects of prostaglandins upon hair growth in mice. Acta Physiol Lat Am. 26:1976;186-191.
38. Ingber D.E. The Architecture of life. Scientific American. 278:1998;48-57.
39. Ingber D.E. Tensegrity. the architectural basis of cellular mechanotransduction Annu Rev Physiol. 59:1997;575-599.
40. Ingber D.E. Cellular tensegrity. defining new rules of biological design that govern the cytoskeleton J Cell Sci. 104:1993;613-627.
41. Jahoda C.A., Reynolds A.J. Dermal-epidermal interactions. Adult follicle-derived cell populations and hair growth. Dermatol Clin. 14:1996;573-583.
42. Jaworsky C., Kligman A.M., Murphy G.F. Characterization of inflammatory infiltrates in male pattern alopecia. implications for pathogenesis Br J Dermatol. 127:1992;239-246.
43. Jimenez de Asua L., Otto A.M., Lindgren J.A., Hammarstrom S. The stimulation of the initiation of DNA synthesis and cell division in Swiss mouse 3T3 cells by prostaglandin F2 alpha requires specific functional groups in the molecule. J Biol Chem. 258:1983;8774-8780.
44. Jindo T., Tsuboi R., Imai R.et al. The effect of hepatocyte growth factor/scatter factor on human hair follicle growth. J Dermatol Sci. 10:1995;229-232.
45. Johnstone M.A. Brief latanoprost therapy induces hypertrichosis. Invest Ophthalmol Vis Sci. 39:1998;S258. [abstract].
46. Johnstone M.A. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 124:1997;544-547.
47. Kaplan E.D., Holbrook K.A. Dynamic expression patterns of tenascin, proteoglycans, and cell adhesion molecules during human hair follicle morphogenesis. Dev Dyn. 199:1994;141-155.
48. Katz M., Wheeler K.E., Radowsky M., Gordon W. Assessment of rate of hair growth using a simple trichometer. Med Biol Eng Comput. 17:1979;333-336.
49. Kaufman K.D. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin. 14:1996;697-711.
50. Kim D.K., Holbrook K.A. The appearance, density, and distribution of Merkel cells in human embryonic and fetal skin. their relation to sweat gland and hair follicle development J Invest Dermatol. 104:1995;411-416.
51. Kleiner M.J., Serur D., Knowles M., Herskovits G. Erythropoietin and abnormal hair growth in hemodialysis patients. Am J Kidney Dis. 18:1991;619. [letter].
52. Kligman A.M. The human hair cycle. J Invest Dermatol. 33:1959;307-316.
53. Kollar E.J. The induction of hair follicles by embryonic dermal papillae. J Invest Dermatol. 55:1970;374-378.
54. Konger R.L., Malaviya R., Pentland A.P. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim Biophys Acta. 1401:1998;221-234.
55. Kurata S., Uno H., Allen-Hoffmann B.L. Effects of hypertrichotic agents on follicular and nonfollicular cells in vitro. Skin Pharmacol. 9:1996;3-8.
56. Kvedar J.C., Baden H.P., Levine L. Selective inhibition by minoxidil of prostacyclin production by cells in culture. Biochem Pharmacol. 37:1988;867-874.
57. Lachgar S., Charveron M., Aries M.F.et al. Effect of VEGF and minoxidil on the production of arachidonic acid metabolites by cultured hair, dermal papilla cells. Euro J Dermatol. 6:1996;365-368.
58. Lachgar S., Charveron M., Bouhaddioui N.et al. Inhibitory effects of bFGF, VEGF and minoxidil on collagen synthesis by cultured hair dermal papilla cells. Arch Dermatol Res. 288:1996;469-473.
59. Lachgar S., Charveron M., Gall Y.et al. Vascular endothelial cells. targets for studying the activity of hair follicle cell-produced VEGF Cell Biol Toxicol. 12:1996;331-334.
60. Lachgar S., Moukadiri H., Jonca F.et al. Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells. J Invest Dermatol. 106:1996;17-23.
61. Last R.J. Wolffs Anatomy of the Eye and Orbit. 1968;W. B. Saunders Co, Philadelphia. ed 6.
62. Lever W.F., Schaumburg-Lever G. Histopathology of the Skin. 1990;J.B. Lippincott Co, Philadelphia.
63. Lindsey J.D., Kashiwagi K., Kashiwagi F., Weinreb R.N. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 38:1997;2214-2223.
64. Link R.E., Paus R., Stenn K.S.et al. Epithelial growth by rat vibrissae follicles in vitro requires mesenchymal contact via native extracellular matrix. J Invest Dermatol. 95:1990;202-207.
65. Little J.C., Redwood K.L., Granger S.P., Jenkins G. In vivo cytokine and receptor gene expression during the rat hair growth cycle. Analysis by semi-quantitative RT-PCR. Exp Dermatol. 5:1996;202-212.
66. Mahrle G, Orfanos CE: Hair colour and hair pigment. Electronmicroscopic investigations on natural and bleached hair (authors transl). Arch Dermatol Forsch 248:109-22, 1973
67. Malkinson F.D., Geng L., Hanson W.R. Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin. J Invest Dermatol. 101:1993;135S-137S.
68. Mansberger S.L., Cioffi G.A. Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Arch Ophthalmol. 118:2000;718-719.
69. Maurer M., Handjiski B., Paus R. Hair growth modulation by topical immunophilin ligands. induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia Am J Pathol. 150:1997;1433-1441.
70. Michelet J.F., Commo S., Billoni N.et al. Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol. 108:1997;205-209.
71. Milam S.B., Magnuson V.L., Steffensen B.et al. IL-1 beta and prostaglandins regulate integrin mRNA expression. J Cell Physiol. 149:1991;173-183.
72. Millar S.E., Miller M.W., Stevens M.E., Barsh G.S. Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated. Development. 121:1995;3223-3232.
73. Millar S.E., Willert K., Salinas P.C.et al. WNT signaling in the control of hair growth and structure. Dev Biol. 207:1999;133-149.
74. Moore G.P., Panaretto B.A., Robertson D. Effects of epidermal growth factor on hair growth in the mouse. J Endocrinol. 88:1981;293-299.
75. Mori O., Uno H. The effect of topical minoxidil on hair follicular cycles of rats. J Dermatol. 17:1990;276-281.
76. Moschella S.L., Hurley H.J. Dermatology. 1992;W.B. Saunders Co, Philadelphia. ed 3.
77. Muller-Rover S., Peters E.J., Botchkarev V.A.et al. Distinct patterns of NCAM expression are associated with defined stages of murine hair follicle morphogenesis and regression. J Histochem Cytochem. 46:1998;1401-1410.
78. Murillas R., Larcher F., Conti C.J.et al. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J. 14:1995;5216-5223.
79. Netland P.A., Landry T., Sullivan E.K.et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 132:2001;472-484.
80. Nicolau G., Baughman R.A., Tonelli A.et al. Deposition of viprostol (a synthetic PGE2 vasodilator) in the skin following topical administration to laboratory animals. Xenobiotica. 17:1987;1113-1120.
81. Noecker R.J. Poster Presentation. 1999;FL: American Academy of Ophthalmology, Orlando.
82. Noecker R.J., Bulau S.A., Schwiegerling J. Xalatan-induced changes in periocular skin pigmentation and lash dimensions measured using a digital imaging technique. Invest Ophthalmol. 40:1999;S832.
83. Noguchi K., Iwasaki K., Ishikawa I. Prostaglandin F2 alpha upregulates intercellular adhesion molecule-1 expression in human gingival fibroblasts. J Periodontal Res. 34:1999;277-281.
84. Novak E., Franz T.J., Headington J.T., Wester R.C. Topically applied minoxidil in baldness. Int J Dermatol. 24:1985;82-87.
85. Noveen A., Jiang T.X., Ting-Berreth S.A., Chuong C.M. Homeobox genes Msx-1 and Msx-2 are associated with induction and growth of skin appendages. J Invest Dermatol. 104:1995;711-719.
86. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res. 67:1998;179-191.
87. Oh H.S., Smart R.C. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA. 93:1996;12525-12530.
88. Orlicky D.J., Lieberman R., Gerschenson L.E. A role for prostaglandins in estrogen growth regulation. Med Hypotheses. 25:1988;1-5.
89. Orlicky D.J., Lieberman R., Williams C., Gerschenson L.E. Effect of phorbol ester on prostaglandin regulation of proliferation in rabbit endometrial cells. Prostaglandins Leukot Essent Fatty Acids. 31:1988;73-81.
90. Panteleyev A.A., Botchkareva N.V., Sundberg J.P.et al. The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol. 155:1999;159-171.
91. Parakkal P.F., Matoltsy A.G. A study of the differentiation products of the hair follicle cells with the electron microscope. J Invest Dermatol. 43:1964;23-34.
92. Paus R., Cotsarelis G. The biology of hair follicles. N Engl J Med. 341:1999;491-497.
93. Paus R., Foitzik K., Welker P.et al. Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling. J Invest Dermatol. 109:1997;518-526.
94. Paus R., Stenn K.S., Link R.E. The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest. 60:1989;365-369.
95. Pinol G, Rueda F, Marti F, et al: [Effect of minoxidil on DNA synthesis in cultured fibroblasts from healthy skin or keloids]. Med Cutan Ibero Lat Am 18:13-7, 1990
96. Randall V.A. Role of 5 alpha-reductase in health and disease. Baillieres Clin Endocrinol Metab. 8:1994;405-431.
97. Randall V.A., Thornton M.J., Hamada K., Messenger A.G. Androgen action in cultured dermal papilla cells from human hair follicles. Skin Pharmacol. 7:1994;20-26.
98. Randall V.A., Thornton M.J., Messenger A.G.et al. Hormones and hair growth. variations in androgen receptor content of dermal papilla cells cultured from human and red deer (Cervus elaphus) hair follicles J Invest Dermatol. 101:1993;114S-120S.
99. Rebora A. Telogen effluvium. Dermatology. 195:1997;209-212.
100. Rhodes L., Harper J., Uno H.et al. The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides). J Clin Endocrinol Metab. 79:1994;991-996.
101. Roenigk H.H. Jr. New topical agents for hair growth. Clin Dermatol. 6:1988;119-121.
102. Rosenquist T.A., Martin G.R. Fibroblast growth factor signalling in the hair growth cycle. expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle Dev Dyn. 205:1996;379-386.
103. Sauk J.J. Jr., White J.G., Witkop C.J. Jr. Influence of prostaglandins E1, E2, and arachidonate on melanosomes in melanocytes and keratinocytes of anagen hair bulbs in vitro. J Invest Dermatol. 64:1975;332-337.
104. Savin R.C., Atton A.V. Minoxidil. Update on its clinical role. Dermatol Clin. 11:1993;55-64.
105. Scandurro A.B., Wang Q., Goodman L.et al. Immortalized rat whisker dermal papilla cells cooperate with mouse immature hair follicle buds to activate type IV procollagenases in collagen matrix coculture. correlation with ability to promote hair follicle development in nude mouse grafts J Invest Dermatol. 105:1995;177-183.
106. Shimaoka S., Tsuboi R., Jindo T.et al. Hepatocyte growth factor/scatter factor expressed in follicular papilla cells stimulates human hair growth in vitro. J Cell Physiol. 165:1995;333-338.
107. Slominski A., Paus R. Melanogenesis is coupled to murine anagen. toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth J Invest Dermatol. 101:1993;90S-97S.
108. St-Jacques B., Dassule H.R., Karavanova I.et al. Sonic hedgehog signaling is essential for hair development. Curr Biol. 8:1998;1058-1068.
109. Staricco R.G. Amelanotic melanocytes in the outer sheath of the human hair follicle and their role in the repigmentation of regenerated epidermis. Ann NY Acad Sci. 100:1963;239-255.
110. Stenn K.S., Combates N.J., Eilertsen K.J.et al. Hair follicle growth controls. Dermatol Clin. 14:1996;543-558.
111. Stenn K.S., Fernandez L.A., Tirrell S.J. The angiogenic properties of the rat vibrissa hair follicle associate with the bulb. J Invest Dermatol. 90:1988;409-411.
112. Stjernschantz J., Selen G., Astin M., Resul B. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Prog Retin Eye Res. 19:2000;459-496.
113. Stjernschantz J.W. From PGF(2alpha)-isopropyl ester to latanoprost. a review of the development of xalatan: the Proctor Lecture Invest Ophthalmol Vis Sci. 42:2001;1134-1145.
114. Tamm E., Lutjen-Drecoll E., Rohen J.W. Age-related changes of the ciliary muscle in comparison with changes induced by treatment with prostaglandin F2 alpha. An ultrastructural study in rhesus and cynomolgus monkeys. Mech Ageing Dev. 51:1990;101-120.
115. Toris C.B., Camras C.B., Yablonski M.E., Brubaker R.F. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 41(Suppl 2):1997;S69-S75.
116. Tosi A., Misciali C., Piraccini B.M.et al. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf. 10:1994;310-317.
117. Uno H., Cappas A., Brigham P. Action of topical minoxidil in the bald stump-tailed macaque. J Am Acad Dermatol. 16:1987;657-668.
118. Uno H., Cappas A., Schlagel C. Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of stumptailed macaques. Am J Dermatopathol. 7:1985;283-297.
119. Uno H., Kurata S. Chemical agents and peptides affect hair growth. J Invest Dermatol. 101:1993;143S-147S.
120. Uno H. Quantitative models for the study of hair growth in vivo. Stenn K.S., Messenger A.G., Baden H.P. Molecular and Structureal Biology of the Hair. 1991;107-124 New York Acad Sci, New York.
121. Wand M. Latanoprost and hyperpigmentation of eyelashes. Arch Ophthalmol. 115:1997;1206-1208.
122. Watanabe T., Nakao A., Emerling D.et al. Prostaglandin F2 alpha enhances tyrosine phosphorylation and DNA synthesis through phospholipase C-coupled receptor via Ca(2+)-dependent intracellular pathway in NIH-3T3 cells. J Biol Chem. 269:1994;17619-17625.
123. Watanabe T., Waga I., Honda Z.et al. Prostaglandin F2 alpha stimulates formation of p21ras-GTP complex and mitogen-activated protein kinase in NIH-3T3 cells via Gq-protein-coupled pathway. J Biol Chem. 270:1995;8984-8990.
124. Weedon D., Strutton G. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol. 61:1981;335-339.
125. Weinberg W.C., Goodman L.V., George C.et al. Reconstitution of hair follicle development in vivo. determination of follicle formation, hair growth, and hair quality by dermal cells J Invest Dermatol. 100:1993;229-236.
126. Wester R.C., Maibach H.I., Guy R.H., Novak E. Minoxidil stimulates cutaneous blood flow in human balding scalps. pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography J Invest Dermatol. 82:1984;515-517.
127. Weston A.H., Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol. 43:1992;47-54.
128. Young R.D. Morphological and ultrastructural aspects of the dermal papilla during the growth cycle of the vibrissal follicle in the rat. J Anat. 131:1980;355-365.
129. Yuspa S.H., Wang Q., Weinberg W.C.et al. Regulation of hair follicle development. an in vitro model for hair follicle invasion of dermis and associated connective tissue remodeling J Invest Dermatol. 101:1993;27S-32S.